Special Purpose Acquisition Company (SPACs)
Viewpoints
Filter by:
Frequently Asked Questions for Private Companies Considering a Reverse Merger
February 13, 2024 | Article | By William Hicks, John T. Rudy
Reverse mergers aren’t an alternative to an IPO, rather they can be a strategic approach for companies looking to go public by leveraging “fallen angels”. Mintz Members Bill Hicks and John Rudy answer frequently asked questions for private companies considering a reverse merger in an article featured in PitchBook’s 2023 Annual US VC Valuations Report. The authors detail the benefits and challenges associated with a reverse merger including finding partners, PIPE financing, Nasdaq access for non-US companies, and SEC implications.
Mintz Represents NET Power on $1.459 Billion Business Combination with Rice Acquisition Corp. II
December 14, 2022
BOSTON – Mintz advised NET Power, LLC, a clean energy technology company whose proprietary technology delivers clean, reliable and low-cost power from natural gas, in its planned business combination with Rice Acquisition Corp II (NYSE: RONI), a special purpose acquisition company (SPAC).
Spotlight on SPACs: The Dog Days of Summer
August 10, 2022
The deal will take public ProKidney, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, and is expected to provide up to $825 million in gross cash proceeds.
Over 55 of the Nation’s Leading Law Firms Respond to Investment Company Act Lawsuits Targeting the SPAC Industry
August 30, 2021 | Blog
SPACS and Scams: FINRA Announces New Sweep Exams
July 26, 2021 | Blog | By Pete Michaels
Webinar Recording: When the Dust Settles: A Closer Look at the SPAC Boom and Potential Litigation to Follow
June 7, 2021 | Webinar | By Nancy Adams, John Sylvia
SPAC Chat Ep. 5: Tempering the SPAC Hype
June 4, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
SPAC Chat Ep. 4: Litigation Update: Preparing for the Next Wave of Suits Against SPACs
April 27, 2021 | Podcast | By Jeffrey Schultz, Sahir Surmeli
Public Benefit Corporations and the SPAC Surge
April 21, 2021 | Blog | By Thomas R. Burton, III, Gianna Nappi
Energy & Sustainability Client Feature: Nuvve Corporation
April 13, 2021 | Article | By Thomas R. Burton, III, Sahir Surmeli
Webinar Recording: Navigate Webinar: Cleantech Goes Public with SPAC
April 7, 2021 | Webinar | By Thomas R. Burton, III
SPAC Chat Ep. 3: Tracking Trends of the SPAC Surge
March 29, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
SPAC Chat Ep. 2: The Controversy Over Sponsor Equity
March 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
MintzTech Connect: All Things Technology — February 2021
February 10, 2021 | | By Daniel DeWolf, Samuel Asher Effron
SPAC Chat: Busting Common Myths about SPACs
February 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
Energy & Sustainability Client Feature: XL Fleet
January 7, 2021 | Article | By Thomas R. Burton, III, Sahir Surmeli
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Election 2024
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology